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In their randomized clinical trial, Suzuki and colleagues1 reported that 
mechanical thrombectomy alone failed to demonstrate noninferiority when compared to 
combined intravenous thrombolysis and mechanical thrombectomy with regard to 
favorable functional outcome at 90 days. We have some concerns about this study.   
First, several baseline characteristics of the patients were not well balanced in the 
treatment groups, as shown in the Table 1. For example, 55% of the patients in the 
mechanical thrombectomy alone group were men vs 70% in the combined intravenous 
thrombolysis and mechanical thrombectomy group. Although imbalances between groups 
can occur by chance in a randomized clinical trial, it is unusual to have imbalances for 
several baseline variables simultaneously, particularly for important prognosis factors in 
patients with stroke, such as blood pressure, stroke severity and stroke location. 
Therefore, we are concerned about systematic bias from the randomization process in this 
open-label trial.  
Second, although the discrepancy between the primary outcome selection in the 
initial and final protocol was explained in the publication, the study hypothesis was not 
clearly stated in the protocol, and did not follow the SPIRIT guidance.2 Additionally, the 
sample size description in both final protocol and statistical analysis plan indicated that 
178 patients were required, assuming a favorable outcome in 48.6% with mechanical 
thrombectomy alone and 35.2% with combined intravenous thrombolysis and mechanical 
thrombectomy. The non-inferiority margin for the primary outcome was not predefined 
or considered in the sample size calculation for this “non-inferiority” trial but was 
compared against an odds ratio of 0.74, derived from a previous meta-analysis. Also, the 
non-inferiority margin was not clearly prespecified but was tested for the secondary 
outcome of modified Rankin Scale score reduction.  
Finally, the percentage of patients projected to drop out of this study decreased 
from 33% in the initial study design to 11% in the final study design. Due to the above 
concerns, we believe further clarifications and justifications are needed to avoid 
misinterpreting the findings of this trial.  
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